Law360, Los Angeles (November 19, 2013, 9:11 PM EST) -- A California federal judge on Tuesday declined to grant final approval of a $25.3 million settlement to resolve multidistrict litigation over recalled dietary supplement Hydroxycut products, finding that the $14 million cy pres distribution fund didn't satisfy standards set forth by the Ninth Circuit.
The judge's decision comes a year after class action plaintiffs in the false marketing suits asked the court to approve the settlement that would resolve the class actions but not individual personal injury suits that are also part of the MDL. The plaintiffs alleged that Kerr Investment Holding Corp., the parent corporation for Hydroxycut maker Iovate Health...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!